Literature DB >> 8382688

Nonresponsiveness of normal human fibroblasts to dioxin correlates with the presence of a constitutive xenobiotic response element-binding factor.

K Gradin1, A Wilhelmsson, L Poellinger, A Berghard.   

Abstract

Polychlorinated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzofuran (TCDF) have been shown to induce transcription of the cytochrome P-450IA1 gene by activating an intracellular receptor protein (the Ah- or dioxin receptor) to bind to specific DNA sequences, termed xenobiotic response elements (XREs). However, the expression and inducibility of the cytochrome P-450IA1 activity exhibit tissue-specific differences. With regard to the TCDF induction response, we have examined three human cell types of endodermal (the hepatoma cell line HepG2), ectodermal (normal keratinocytes), and mesodermal origin (normal fibroblasts). DNase I hypersensitivity analysis of the 5' flank and first intron of the P-450IA1 gene showed that in the nonresponsive fibroblasts the chromatin structure lacked open regions while in the two responsive cell types (keratinocytes and HepG2) several constitutive hypersensitive sites as well as TCDF-induced alterations in the chromatin structure could be detected. This observation might correlate with the fact that the XRE, in either the context of the P-450IA1 gene sequences or in front of a heterologous promoter, was inefficient in directing a TCDF induction response in fibroblasts. In in vitro DNA binding studies, the dioxin receptor was activated to a DNA-binding nuclear form in all three cell types. However, in fibroblast nuclear extracts two novel constitutive protein-XRE complexes were detected. The fibroblast factor(s) were immunochemically distinct from the receptor but exhibited indistinguishable DNA binding specificity. These data are compatible with a model where the P-450IA1 is noninducible in fibroblasts due to the presence of a putative repressor(s) which may compete effectively with the receptor for binding to the response element as indicated by in vitro DNA-binding off-rate experiments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events.

Authors:  Heike C Hawerkamp; Andreas Kislat; Peter A Gerber; Marius Pollet; Katharina M Rolfes; Anatoly A Soshilov; Michael S Denison; Afaque A Momin; Stefan T Arold; Angeliki Datsi; Stephan A Braun; Péter Oláh; Mario E Lacouture; Jean Krutmann; Thomas Haarmann-Stemmann; Bernhard Homey; Stephan Meller
Journal:  Allergy       Date:  2019-09-03       Impact factor: 13.146

2.  Interactions of polybrominated diphenyl ethers with the aryl hydrocarbon receptor pathway.

Authors:  A K Peters; S Nijmeijer; K Gradin; M Backlund; A Bergman; L Poellinger; M S Denison; M Van den Berg
Journal:  Toxicol Sci       Date:  2006-04-06       Impact factor: 4.849

3.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.

Authors:  M B Kumar; G H Perdew
Journal:  Gene Expr       Date:  1999

4.  Aryl hydrocarbon receptor/dioxin receptor in human monocytes and macrophages.

Authors:  K Komura; S Hayashi; I Makino; L Poellinger; H Tanaka
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

5.  Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor.

Authors:  K Gradin; J McGuire; R H Wenger; I Kvietikova; M L fhitelaw; R Toftgård; L Tora; M Gassmann; L Poellinger
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator.

Authors:  Brad R Evans; Sibel I Karchner; Lenka L Allan; Richard S Pollenz; Robert L Tanguay; Matthew J Jenny; David H Sherr; Mark E Hahn
Journal:  Mol Pharmacol       Date:  2007-11-13       Impact factor: 4.436

7.  Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor.

Authors:  M Reick; R W Robertson; D S Pasco; J B Fagan
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

8.  Protein-protein interaction via PAS domains: role of the PAS domain in positive and negative regulation of the bHLH/PAS dioxin receptor-Arnt transcription factor complex.

Authors:  M C Lindebro; L Poellinger; M L Whitelaw
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

9.  Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells.

Authors:  W L Wang; J S Thomsen; W Porter; M Moore; S Safe
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor.

Authors:  Olga Brandstätter; Oliver Schanz; Julia Vorac; Jessica König; Tetsushi Mori; Toru Maruyama; Markus Korkowski; Thomas Haarmann-Stemmann; Dorthe von Smolinski; Joachim L Schultze; Josef Abel; Charlotte Esser; Haruko Takeyama; Heike Weighardt; Irmgard Förster
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.